Lipofuscin, Its Origin, Properties, and Contribution to Retinal Fluorescence as a Potential Biomarker of Oxidative Damage to the Retina

“

TL;DR

This review examines lipofuscin accumulation in retinal pigment epithelium (RPE) as a key contributor to retinal fluorescence and a potential biomarker of oxidative damage in age-related macular degeneration (AMD). It synthesizes evidence that oxidative stress and lysosomal dysfunction drive lipofuscin formation, and that photooxidation of lipofuscin shifts its fluorescence from yellow-red to blue-green, a spectral change detectable in AMD retinas. Clinically, imaging these spectral shifts may enable noninvasive monitoring of oxidative damage and assessment of antioxidant therapies in retinal degenerations.

Full summary

4,930 CHARS

**Background** Lipofuscin is an autofluorescent intracellular pigment that accumulates with age in postmitotic cells, particularly in the retinal pigment epithelium (RPE), due to incomplete lysosomal digestion of phagocytosed photoreceptor outer segments (POS) and autophagocytosed material. Its accumulation is accelerated by oxidative stress and lysosomal dysfunction. In the retina, RPE lipofuscin is the major source of fundus autofluorescence excited by ultraviolet, blue, and green light. Lipofuscin contains bisretinoids (e.g., A2E) and oxidation products of polyunsaturated fatty acids, especially docosahexaenoic acid (DHA). Photoexcitation of lipofuscin generates reactive oxygen species (singlet oxygen, superoxide) that can damage RPE cells and contribute to age-related macular degeneration (AMD), a leading cause of blindness in the elderly. This review aims to update the understanding of lipofuscin formation, its fluorescence properties, and its potential as a biomarker of oxidative damage in the retina.

**Methods** This is a narrative review synthesizing evidence from in vitro studies, animal models, ex vivo human retinal tissue analyses, and clinical imaging studies. The author discusses the biochemical composition of lipofuscin, its formation mechanisms (including the roles of oxidative stress, autophagy/lysosomal dysfunction, and vitamin A derivatives), and its photosensitizing properties. Fluorescence spectroscopy and imaging techniques (e.g., confocal scanning laser ophthalmoscopy, two-photon excitation fluorescence, hyperspectral imaging) are reviewed for their ability to detect lipofuscin fluorescence and its spectral changes upon oxidation. Epidemiological studies on sunlight exposure and AMD, as well as clinical trials of antioxidant therapies (e.g., AREDS, deuterated vitamin A), are summarized to contextualize the clinical relevance.

**Key Results** - Lipofuscin accumulates in RPE cells, occupying up to 19% of cytoplasmic area in donors aged 81–90 years. Its formation is accelerated by oxidative stress: dietary depletion of vitamin E in rats led to a 3.9-fold increase in RPE lipofuscin by morphometry and a 2.3-fold increase by fluorescence. Conversely, vitamin A depletion reduced lipofuscin accumulation. - RPE lipofuscin exhibits broad fluorescence emission with a maximum at 580–630 nm when excited with UV or blue light. Photooxidation of lipofuscin in vitro causes a dose-dependent decrease in yellow-red fluorescence (above 560 nm) and a concomitant increase in blue-green fluorescence (380–520 nm). Similar spectral shifts are observed in lipofuscin-laden ARPE-19 cells exposed to sublethal visible light. - In vivo, fundus autofluorescence increases with age up to the seventh decade, then plateaus or decreases for long-wavelength emission (650–750 nm). In AMD retinas, the fluorescence emission maximum shifts to shorter wavelengths: in one study, AMD retinas exhibited maxima at 571 ± 26 nm (fovea), 596 ± 17 nm (inner ring), and 602 ± 16 nm (outer ring), compared to 602 ± 16, 614 ± 12, and 621 ± 11 nm in age-matched controls (p < 0.05). - The ratio of green-yellow (530–580 nm) to orange-red (600–650 nm) fluorescence in RPE cell suspensions was 1.04 ± 0.11 for normal eyes and 1.73 ± 0.16 for AMD eyes, indicating a significant shift toward shorter wavelengths. - In a clinical trial of deuterated vitamin A (ALK-001) in Stargardt’s disease patients, the growth rate of geographic atrophy lesions was 21% slower in the treated group than in the placebo group (p < 0.001). - Epidemiological meta-analyses show mixed associations between sunlight exposure and AMD: one meta-analysis of 14 studies reported a pooled odds ratio of 1.10 (95% CI: 0.98–1.23), while another reported a significant association (OR = 1.379; 95% CI: 1.091–1.745).

**Clinical Implications** The spectral shift of lipofuscin fluorescence from yellow-red to blue-green upon oxidation provides a potential noninvasive biomarker for oxidative damage in the retina. Current fundus autofluorescence imaging uses excitation wavelengths (e.g., 488 nm) that are suboptimal for detecting this shift; the author suggests using shorter excitation wavelengths (e.g., 460 nm) and collecting emission in the blue (470–490 nm) and yellow-red (560–700 nm) ranges to improve sensitivity. Two-photon excitation fluorescence with 920 nm laser pulses and adaptive optics may enable safe, layer-specific imaging of RPE lipofuscin oxidation in vivo. Such imaging could be used to monitor disease progression in AMD and Stargardt’s disease, and to evaluate the efficacy of antioxidant therapies (e.g., deuterated vitamin A, deuterated DHA, inhibitors of the retinoid cycle). The review also highlights the need for better quantification of retinal light exposure in epidemiological studies and for further research into the relative contributions of lipofuscin and retinaldehydes to light-induced retinal injury.